Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)



Status:Active, not recruiting
Conditions:Colorectal Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:50 - 75
Updated:1/11/2019
Start Date:April 30, 2012
End Date:September 29, 2028

Use our guide to learn which trials are right for you!

CSP #577 - Colonoscopy vs. Fecal Immunochemical Testing in Reducing Mortality From Colorectal Cancer

Colorectal cancer (CRC) is currently the second most common cause of cancer death in the
United States, and one of the most preventable cancers. It has been shown in several
randomized controlled trials that screening using fecal occult blood testing (FOBT) reduces
CRC mortality by 13-33%. While there is strong consensus amongst experts regarding the value
of CRC screening, the best approach to screening is not clear. Of the widely recommended
modalities, FOBT and colonoscopy are the most commonly used within the United States. FOBT is
inexpensive, non-invasive, and its use as a screening tool is supported by the highest
quality evidence (i.e. randomized controlled trials). Moreover, newer FOBT, such as fecal
immunochemical tests or FITs, have advantages over conventional FOBT in terms of both test
characteristics and ease of use that make them quite attractive as a population-based
screening tool.

While colonoscopy is invasive and has higher up-front risks and costs than FOBT, it does
afford the opportunity to directly assess the colonic mucosa and is widely believed to be the
best test to detect colorectal cancer. In addition, colonoscopy allows for the detection and
removal of colorectal adenomas -a well recognized colorectal cancer precursor. There is
indirect evidence that suggests colonoscopy is effective in reducing colorectal cancer
mortality, but to date, no large clinical trials have been completed to support this
assumption. While colonoscopy use is increasing, data is emerging that colonoscopy may not be
as effective as previously believed. Prior support for colonoscopy as a screening test relied
upon effectiveness estimates that now appear to be overly optimistic. Given the invasive
nature of colonoscopy, the associated small, but real risk of complications, and dramatically
higher costs than other screening tests, it is especially important to determine the true
comparative effectiveness of colonoscopy relative to other proven non-invasive options.

The investigators propose to perform a, large, simple, multicenter, randomized, parallel
group trial directly comparing screening colonoscopy with annual FIT screening in average
risk individuals. The hypothesis is that colonoscopy will be superior to FIT in the
prevention of colorectal cancer mortality measured over 10 years. Individuals will be
enrolled if they are currently eligible for CRC screening (e.g. no colonoscopy in the past 10
years and no FOBT in the past 1 year) and are between 50 and 75 years of age. The
investigators will exclude individuals for whom colonoscopy is indicated (e.g. signs or
symptoms of CRC, first degree family member with CRC, personal history of colorectal
neoplasia or inflammatory bowel disease).

All participants will complete baseline demographic, medication, and lifestyle questionnaires
(e.g. diet, non-steroidal anti-inflammatory use, frequency of exercise) prior to
randomization in a 1:1 ratio to either screening colonoscopy or annual FIT screening (Figure
1). Those testing positive by FIT will undergo evaluation to determine appropriateness for
colonoscopy. Screening will be performed in a manner consistent with the currently accepted
standard of care in order to determine the comparative effectiveness of the two screening
strategies. Participants will be surveyed annually to determine if they have undergone
colonoscopy or been diagnosed with CRC.

The primary study endpoint will be CRC mortality within 10 years of enrollment. The secondary
endpoints are (1) the incidence of CRC within 10 years of enrollment and (2) major
complications of colonoscopy. Mortality will be determined through queries of the VA Vital
Status File. Cause of death will be determined primarily using death certificates from the
National Death Index-Plus database, augmented by adjudication of medical records for known
CRC cases where CRC is not listed as a cause of death on the death certificate. The
investigators postulate that screening colonoscopy will result in a 40% reduction in CRC
mortality over 10 years relative to annual FIT screening. Using a log-rank test with a
2-sided test of significance, =0.05, a sample size of 50,000 participants will be required to
test the primary hypothesis with 82% power, assuming a 1% annual rate of crossover from FIT
to colonoscopy and a 0.5% annual rate of loss to follow-up. The planned study duration is
12.5 years with 2.5 years of recruitment and 10 years of follow-up for all enrolled
participants.


Inclusion Criteria:

- Male and female adults aged 50-75 years of age

- Veteran

- Able to provide informed consent

Exclusion Criteria:

- Symptoms of lower gastrointestinal tract disease warranting colonoscopic evaluation,
including:

- More than one episode of rectal bleeding within the past 6 months

- Documented iron deficiency anemia

- Significant documented unintentional weight loss (>10% of baseline weight) over 6
months

- Family history of CRC in a first degree relative at any age

- Prior history of colonic disease including:

- Inflammatory bowel disease (e.g. ulcerative colitis or Crohn's disease)

- One or more colorectal neoplastic polyps (i.e. adenomas)

- Colorectal cancer

- Prior history of colonic resection

- Prior colonic examination, including:

- Colonoscopy within the past 9.5 years

- Sigmoidoscopy within the past 5 years

- Barium enema within the past 5 years

- CT colonography within the past 5 years

- gFOBT or FIT in the past 10 months

- Stool DNA test within the past 3 years

- Pregnancy

- Prisoner

- Significant comorbidity that would preclude benefit from screening or pose significant
risk for the performance of colonoscopy (e.g. severe lung disease, end-stage renal
disease, end-stage liver disease, severe heart failure, recent diagnosis of cancer
(with the exception of non-melanoma skin cancer))

- Participation in a concurrent interventional study pertaining to the colon or rectum
(including studies of colonoscopy or colorectal cancer screening. Waivers to this
exclusion criteria can be requested and granted with the approval of the CONFIRM study
co-chairs, the Cooperative Study Program and the leadership of the other study.

- Likely inability to track the individual over time (e.g. no permanent address at the
time of screening for study entry)
We found this trial at
46
sites
Fresno, California 93703
Phone: 559-225-6100
?
mi
from
Fresno, CA
Click here to add this to my saved trials
Ann Arbor, Michigan 48113
Phone: 734-845-5795
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Boston, Massachusetts 02130
Phone: 857-364-4327
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Clarksburg, West Virginia 26301
Phone: 304-623-7617
?
mi
from
Clarksburg, WV
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Decatur, Georgia 30033
Phone: 404-321-6111
?
mi
from
Decatur, GA
Click here to add this to my saved trials
Denver, Colorado 80220
Phone: 303-399-8020
?
mi
from
Denver, CO
Click here to add this to my saved trials
Detroit, Michigan 48201
Phone: 313-576-3389
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Durham, North Carolina 27705
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
East Orange, NJ
Click here to add this to my saved trials
Gainesville, Florida 32608
Phone: 352-376-1611
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
Houston, Texas 77030
Phone: 713-794-7274
?
mi
from
Houston, TX
Click here to add this to my saved trials
Indianapolis, Indiana 46202
Phone: 317-988-2223
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Kansas City, Missouri 64128
Phone: 818-861-4711
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
Loma Linda, California 92357
Phone: 909-825-7084
?
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Long Beach, California 90822
Phone: 562-826-5628
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Madison, Wisconsin 53705
Phone: 608-213-4070
?
mi
from
Madison, WI
Click here to add this to my saved trials
Manchester, New Hampshire 03104
Phone: 802-295-9363
?
mi
from
Manchester, NH
Click here to add this to my saved trials
Memphis, Tennessee 38104
?
mi
from
Memphis, TN
Click here to add this to my saved trials
Miami, Florida 33125
Phone: 305-575-7000
?
mi
from
Miami, FL
Click here to add this to my saved trials
Minneapolis, Minnesota 55417
Phone: 612-467-4100
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Northport, New York 11768
Phone: 631-261-4400
?
mi
from
Northport, NY
Click here to add this to my saved trials
Oklahoma City, Oklahoma 73104
Phone: 405-456-1000
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19106
Phone: 215-823-5800
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phoenix, Arizona 85012
Phone: 602-277-5551
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Portland, OR
Click here to add this to my saved trials
Providence, Rhode Island 02908
Phone: 401-273-7100
?
mi
from
Providence, RI
Click here to add this to my saved trials
Richmond, Virginia 23249
Phone: 804-675-5021
?
mi
from
Richmond, VA
Click here to add this to my saved trials
915 North Grand Boulevard
Saint Louis, Missouri 63106
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
?
mi
from
Salisbury, NC
Click here to add this to my saved trials
Salt Lake City, Utah 84148
Phone: 801-582-1565
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
San Diego, California 92161
Phone: 858-642-3280
?
mi
from
San Diego, CA
Click here to add this to my saved trials
San Juan, 00921
Phone: 787-641-3669
?
mi
from
San Juan,
Click here to add this to my saved trials
Seattle, Washington 98108
Phone: 206-764-2285
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Tampa, Florida 33612
Phone: 813-972-2000
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Washington, District of Columbia 20422
Phone: 202-745-8455
?
mi
from
Washington,
Click here to add this to my saved trials
West Haven, Connecticut 06516
Phone: 203-932-5711
?
mi
from
West Haven, CT
Click here to add this to my saved trials
West Los Angeles, California 90073
Phone: 310-268-3578
?
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
White River Junction, Vermont 05009
Phone: 802-295-9363
?
mi
from
White River Junction, VT
Click here to add this to my saved trials